Vaxil Bio Balance Sheet Health
Financial Health criteria checks 6/6
Vaxil Bio has a total shareholder equity of CA$891.0K and total debt of CA$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CA$976.0K and CA$85.0K respectively.
Key information
0%
Debt to equity ratio
CA$0
Debt
| Interest coverage ratio | n/a |
| Cash | CA$938.00k |
| Equity | CA$891.00k |
| Total liabilities | CA$85.00k |
| Total assets | CA$976.00k |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VXL's short term assets (CA$976.0K) exceed its short term liabilities (CA$85.0K).
Long Term Liabilities: VXL has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: VXL is debt free.
Reducing Debt: VXL had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: VXL has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: VXL has sufficient cash runway for 1.4 years if free cash flow continues to grow at historical rates of 3.3% each year.